dexmethylphenidate 2.5 mg

1 INDICATIONS AND USAGE Dexmethylphenidate hydrochloride tablets is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)]. Dexmethylphenidate hydrochloride tablets is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) (1).

kvk-tech, inc

FDA Reported Adverse Reactions
`[1] fatigue` `[2] off label use` `[3] drug ineffective` `[4] pain` `[5] nausea` `[6] headache` `[7] dyspnoea` `[8] arthralgia` `[9] pyrexia` `[10] toxicity to various agents`

5 years ago

ROUND BLUE A1

5 years ago

A1 ROUND BLUE

16 HOW SUPPLIED/STORAGE AND HANDLING

DEXMETHYLPHENIDATE HYDROCHLORIDE tablets, 2.5 mg are blue, round, biconvex tablets debossed “A1” on one side and plain on the other side. Bottles of 100………………. NDC 10702-0106-01

DEXMETHYLPHENIDATE HYDROCHLORIDE tablets, 5 mg are yellow, round, biconvex tablets debossed “A2” on one side and plain on the other side. Bottles of 100………………. NDC 10702-0107-01

DEXMETHYLPHENIDATE HYDROCHLORIDE tablets, 10 mg are white, round, biconvex tablets, debossed “A3” on one side and plain on the other side. Bottles of 100………………. NDC 10702-0108-01 Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Dispense in tight, light-resistant container (USP).

More pills like ROUND A1

Related Pills

dexmethylphenidate 5 mg

kvk-tech, inc

dexmethylphenidate 10 mg

kvk-tech, inc

vitamin d folic acid

amella pharma llc

anastrozole 1 MG Oral Tablet

Sun Pharmaceutical Industries Limited

low dose aspirin aspirin tablet coated

akron phama

Zolpidem tartrate 12.5 MG Extended Release Tablet

Actavis Pharma, Inc.

alyacen 777 norethindrone and ethinyl estradiol kit alyacen 135 norethindrone and ethinyl estradiol kit

glenmark pharmaceuticals inc., usa

Zolpidem tartrate 12.5 MG Extended Release Tablet

Actavis Elizabeth LLC

amlodipine as amlodipine besylate 10 MG Oral Tablet

Mylan Pharmaceuticals Inc.

Zolpidem Tartrate Zolpidem tartrate 6.25 MG Extended Release Oral Tablet

Par Pharmaceutical, Inc.

amlodipine besylate tablet

mylan pharmaceuticals inc.

alprazolam tablet

mylan pharmaceuticals inc.

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site